http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018177643-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01241009763a23c456961dec3a6119af
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2017-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22fd079cf472567126b10030907544f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ac7e587c52880c96c653be0a036c9a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec9423a2e23ec64ebcc5600532fc0a89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dc94038bf9b5dcf369e6060fbe3a30a
publicationDate 2018-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2018177643-A
titleOfInvention Transdermal collagen production promoter and method for promoting production of type I procollagen
abstract PROBLEM TO BE SOLVED: To provide a novel percutaneous collagen production promoter capable of promoting the production of type I procollagen, which is a precursor substance of type I collagen producing fibrillar collagen, and capable of fundamentally solving skin aging, and type I collagen Providing methods for promoting the production of A percutaneous collagen production promoter comprising hydrolyzed hyaluronic acid having an average molecular weight of 3,500 or less and / or a salt thereof as an active ingredient. It is preferable that the salt of the said hydrolyzing hyaluronic acid is a sodium salt, and it is preferable that the hypertensive residue is 15 to 25%, The collagen production promoter for percutaneous formations for which it is preferable. A method for promoting the production of type I collagen, wherein the promoter is applied to the skin. 【Selection chart】 None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019082922-A1
priorityDate 2017-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013180990-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016169188-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014227350-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1278
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12843
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84352
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139

Total number of triples: 40.